\n \nClarithromycin USP \n \nComposition :?Clarithromycin USP 250mg & 500mg Tablet. \n \nIndication :?Clarin is indicated for the treatment of mild to moderate infections like pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia, uncomplicated skin and skin structure infections, disseminated mycobacterial infections. \n \nDosage and administration :?Usual dose is 250mg twice daily, may be increased to 500mg twice daily, if necessary in severe infection. A course is usually for 7 to 14 days. In patients with severe renal impairment dosage may need to be halved to 250mg once daily or 250mg twice daily in severe infection or as directed by a registered physician. \n \nPregnancy and lactation :Clarithromycin has been assigned to pregnancy category B by the FDA. Clarithromycin is likely to be excreted into the breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the benefit of the drug to the mother \n \nPacking :?Clarin-250 : 1 x 10's tablets in blister pack. \n \nClarin-500 : 1 x 10's tablets in blister pack. \n \n